SRNE Sorrento Therapeutics Inc

Sorrento Therapeutics Inc is a biotechnology company focused on the development of novel immunotherapies for oncology and autoimmune/inflammation diseases.

$5.24  +0.29 (5.87%)
As of 12/06/2021 15:59:58 EST     IEX book   CBOE book

Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Small cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  USA
Country of incorporation:  USA
IPO date:  12/31/2009
Outstanding shares:  306,335,789
Average volume:  5,291,593
Market cap:   $1,687,910,197
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
CUSIP:    83587F202
ISIN:        US83587F2020
Sedol:      BCT5QQ7
Valuation   (See tab for details)
PE ratio:   -4.26
PB ratio:   11.14
PS ratio:   32.88
Return on equity:   -270.27%
Net income %:   -692.36%

2021 © Stock Market MBA, Inc. Terms of use | Privacy policy